Efpeglenatide
- Generic Name
- Efpeglenatide
- Drug Type
- Biotech
- CAS Number
- 1296200-77-5
- Unique Ingredient Identifier
- 3M1V5Z2270
- Background
Efpeglenatide is under investigation in clinical trial NCT03713684 (Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)).
A Study of HM11260C in Healthy Male Subject
- First Posted Date
- 2010-03-26
- Last Posted Date
- 2014-02-07
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 41
- Registration Number
- NCT01093729
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath